2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Revenue | $67M | $151M | $198M | $242M | $296M |
Cost of Revenue | $25M | $55M | $94M | $154M | $155M |
Gross Profit | $43M | $96M | $104M | $87M | $141M |
Gross Profit % | 65% | 64% | 52% | 36% | 48% |
R&D Expenses | $0 | $0 | $0 | $0 | $0 |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Net Income | $24M | $11M | $29M | -$7.1M | $20M |
Dep. & Amort. | $16M | $31M | $27M | $30M | $28M |
Def. Tax | -$30M | -$8.1M | $3.7M | $3.8M | $0 |
Stock Comp. | $714K | $4.9M | $19M | $35M | $30M |
Chg. in WC | -$1.2M | -$6.9M | -$19M | -$16M | -$7.6M |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Cash | $12M | $41M | $20M | $30M | $67M |
ST Investments | $0 | $0 | $2.3M | $0 | $0 |
Cash & ST Inv. | $12M | $41M | $20M | $30M | $67M |
Receivables | $5.2M | $18M | $57M | $84M | $114M |
Inventory | $19M | $64M | $1 | $0 | $0 |
P10 exceeded its 2024 financial and operating guidance, achieving $3.8 billion in gross fundraising, a 23% revenue increase, and a 17% rise in adjusted EBITDA.
The company provided a 2025 outlook with a gross fundraising target of at least $4 billion, excluding $1 billion in incremental fee-paying assets from the Qualitas Funds acquisition.
P10 aims to double its fee-paying AUM to $50 billion by 2029, with most growth expected to be organic, complemented by strategic M&A.
FRE margins are projected to remain in the mid-40% range for 2025, with long-term expansion to closer to 50% driven by operating leverage and strategic investments.
The company repurchased $59.1 million in shares during 2024 and authorized an additional $40 million for share buybacks, reflecting confidence in its growth strategy and shareholder value creation.